To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Late PONV reduced with ramosetron vs ondansetron following TKA under spinal anesthesia

Download
Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
October 2017

Late PONV reduced with ramosetron vs ondansetron following TKA under spinal anesthesia

Vol: 6| Issue: 10| Number:21| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A

Comparison of Ramosetron With Ondansetron for Prevention of Intrathecal Morphine-Induced Nausea and Vomiting After Primary Total Knee Arthroplasty: A Randomized Control Trial

J Arthroplasty. 2017 Mar;32(3):1040-1043

Contributing Authors:
P Pinsornsak M Teeyaphudit C Ruetiwarangkoon A Chaiwuttisak

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

90 patients scheduled for total knee arthroplasty under spinal anesthesia and intrathecal morphine were randomized to antiemesis with either ramosetron or ondansetron. Patients were assessed for the incidence of nausea and vomiting, and severity of nausea, over the first 48 hours postoperatively. Results demonstrated a significantly lower incidence of nausea in the ramosetron group compared to the...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue